Benefits Strategy

Biosimilars: Reviving the Conversation Amid Shifting Market Tides

Though biosimilar approvals and utilization have increased, market dynamics have prevented employers from realizing their full cost savings potential.

March 11, 2025

This content is for members only. Already a member? Login

Join today to gain access to member-only resources!

More in Benefits Strategy

TABLE OF CONTENTS

Headwinds and Tailwinds to Uptake
Employer Recommendations